Mirum Pharmaceuticals (MIRM) Assets Growth (5y) (2023 - 2026)

Mirum Pharmaceuticals (MIRM) Assets Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mirum Pharmaceuticals 6.73 Bn 6.34 Bn 131.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.01%
Dec 31, 2025 28.47%
Sep 30, 2025 40.80%
Jun 30, 2025 36.04%
Mar 31, 2025 31.91%
Dec 31, 2024 35.53%
Sep 30, 2024 33.37%
Jun 30, 2024 44.67%
Dec 31, 2023 65.57%